Literature DB >> 26521664

Is there a differential conversion of artesunate to dihydroartemisinin in pregnant vs. post-partum patients with malaria after oral artesunate dosing?

Nuggehally R Srinivas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26521664      PMCID： PMC4833162          DOI： 10.1111/bcp.12809

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Is there a differential conversion of artesunate to dihydroartemisinin in pregnant vs. post-partum patients with malaria after oral artesunate dosing?

Authors:  Nuggehally R Srinivas
Journal:  Br J Clin Pharmacol       Date:  2015-12-01       Impact factor: 4.335

2.  Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases.

Authors:  Kenneth F Ilett; Brian T Ethell; James L Maggs; Timothy M E Davis; Kevin T Batty; Brian Burchell; Tran Quang Binh; Le Thi Anh Thu; Nguyen Canh Hung; Munir Pirmohamed; B Kevin Park; Geoffrey Edwards
Journal:  Drug Metab Dispos       Date:  2002-09       Impact factor: 3.922

3.  Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.

Authors:  Innocent Valea; Halidou Tinto; Maminata Traore-Coulibaly; Laeticia C Toe; Niklas Lindegardh; Joel Tarning; Jean-Pierre Van Geertruyden; Umberto D'Alessandro; Geraint R Davies; Stephen A Ward
Journal:  J Antimicrob Chemother       Date:  2014-06-02       Impact factor: 5.790

4.  Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.

Authors:  Xue-Qing Li; Anders Björkman; Tommy B Andersson; Lars L Gustafsson; Collen M Masimirembwa
Journal:  Eur J Clin Pharmacol       Date:  2003-08-12       Impact factor: 2.953

Review 5.  Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.

Authors:  Carrie A Morris; Stephan Duparc; Isabelle Borghini-Fuhrer; Donald Jung; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  Malar J       Date:  2011-09-13       Impact factor: 2.979

6.  Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.

Authors:  Rose McGready; Aung Pyae Phyo; Marcus J Rijken; Joel Tarning; Niklas Lindegardh; Warunee Hanpithakpon; Hla Hla Than; Nathar Hlaing; Naw Thida Zin; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

7.  Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.

Authors:  Frank Kloprogge; Rose McGready; Aung Pyae Phyo; Marcus J Rijken; Warunee Hanpithakpon; Hla Hla Than; Nathar Hlaing; Naw Thida Zin; Nicholas P J Day; Nicholas J White; François Nosten; Joel Tarning
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335
  7 in total
  2 in total

1.  Is there a differential conversion of artesunate to dihydroartemisinin in pregnant vs. post-partum patients with malaria after oral artesunate dosing?

Authors:  Nuggehally R Srinivas
Journal:  Br J Clin Pharmacol       Date:  2015-12-01       Impact factor: 4.335

2.  Response to "Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction".

Authors:  Prasanna Jagannathan; Richard Kajubi; Francesca T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2018-01-11       Impact factor: 6.875
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.